Publications in collaboration with researchers from Hospital Universitario Virgen de las Nieves (26)

2023

  1. Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma

    Cancers, Vol. 15, Núm. 14

2021

  1. Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma

    Molecular Oncology, Vol. 15, Núm. 2, pp. 407-428

2020

  1. Uncovering tumour heterogeneity through PKR and nc886 analysis in metastatic colon cancer patients treated with 5-FU-based chemotherapy

    Cancers, Vol. 12, Núm. 2

2018

  1. Activating transcription factor 4 modulates TGFb-induced aggressiveness in triple-negative breast cancer via SMad2/3/4 and mTORC2 signaling

    Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5697-5709

  2. Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile

    Cancer Letters, Vol. 429, pp. 78-88

2017

  1. A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: A pilot study focused on pancreatic and ovarian cancer

    Scientific Reports, Vol. 7, Núm. 1

  2. Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism

    Expert Reviews in Molecular Medicine, Vol. 19

  3. Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity

    Scientific Reports, Vol. 7

2016

  1. Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells

    Scientific Reports, Vol. 6

  2. Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what’s new?

    Expert Opinion on Therapeutic Patents, Vol. 26, Núm. 8, pp. 877-890

2015

  1. Erratum to "Cardiomyogenic differentiation potential of human endothelial progenitor cells isolated from patients with myocardial infarction" (Cytotherapy 2014;16:1229-1237)

    Cytotherapy

2014

  1. Cardiomyogenic differentiation potential of human endothelial progenitor cells isolated from patients with myocardial infarction

    Cytotherapy, Vol. 16, Núm. 9, pp. 1229-1237

  2. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

    Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497

  3. HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound

    Oncotarget, Vol. 5, Núm. 11, pp. 3590-3606

  4. The impact of PKR activation: From neurodegeneration to cancer

    FASEB Journal, Vol. 28, Núm. 5, pp. 1965-1974

2013

  1. Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence

    Drug Design, Development and Therapy, Vol. 7, pp. 1301-1313

  2. Enantiospecific synthesis of heterocycles linked to purines: Different apoptosis modulation of enantiomers in breast cancer cells

    Current Medicinal Chemistry, Vol. 20, Núm. 38, pp. 4924-4934

  3. How can nanotechnology help to repair the body? Advances in cardiac, skin, bone, cartilage and nerve tissue regeneration

    Materials, Vol. 6, Núm. 4, pp. 1333-1359

  4. In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation

    Cellular Oncology, Vol. 36, Núm. 4, pp. 289-301

2012

  1. Functionalized nanostructures with application in regenerative medicine

    International Journal of Molecular Sciences, Vol. 13, Núm. 3, pp. 3847-3886